Clinical Research Directory
Browse clinical research sites, groups, and studies.
SUPRAFLEX CRUZ PMCF Study ( rEpic05 )
Sponsor: Fundación EPIC
Summary
Multicenter, prospective, non-randomized, post-market clinical follow-up (PMCF) study to confirm and support the clinical safety and performance of Medical Device Regulations (MDR) with multivessel coronary disease requirements in all the CONSECUTIVE patients treated with (SUPRAFLEX CRUZ).
Official title: SUPRAFLEX CRUZPost-Market Clinical Follow-up Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
508
Start Date
2023-05-10
Completion Date
2026-12-01
Last Updated
2025-12-16
Healthy Volunteers
No
Interventions
SUPRAFLEX CRUZ
Patients in whom treatment with SUPRAFLEX CRUZ has been attempted
Locations (21)
Hospital General Universitario de Elche
Elche, Alicante, Spain
Hospital Universitario A Coruña
A Coruña, Spain
Hospital Universitario de Cruces
Barakaldo, Spain
Hospital Universitari Vall D'Hebron
Barcelona, Spain
Hospital de La Santa Creu I Sant Pau
Barcelona, Spain
Hospital General Universitario de Castellón
Castelló, Spain
Hospital Universitario San Pedro de Alcántara
Cáceres, Spain
Hospital General Universitario de Ciudad Real
Ciudad Real, Spain
Hospital Universitari Dr. Josep Trueta
Girona, Spain
Hospital Universitario Clínico San Cecilio
Granada, Spain
Hospital Universitario de Leon
León, Spain
Hospital Universitari Arnau de Vilanova
Lleida, Spain
Hospital Universitario 12 de Octubre
Madrid, Spain
Hospital Clínico Universitario Virgen de la Arrixaca
Murcia, Spain
Hospital Parc Tauli
Sabadell, Spain
Hospital Clinico Universitario de Salamanca
Salamanca, Spain
Hospital Clínico Universitario de Santiago de Compostela
Santiago de Compostela, Spain
Hospital Universitario Virgen Del Rocio
Seville, Spain
Hospital Universitario de Toledo
Toledo, Spain
Hospital Universitario Y Politécnico La Fé
Valencia, Spain
Hospital Universitario Lozano Blesa
Zaragoza, Spain